TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11083486

Group type: EXPERIMENTAL
Intervention: Rutin supplementation (500 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (glucose equivalent)
Number of subjects: 18
Study: 8633816

Group type: EXPERIMENTAL
Intervention: Combination therapy (zidovudine with didanosine or zalcitabine)
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: Sequential monotherapy (with didanosine or zalcitabine)
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Zidovudine monotherapy
Number of subjects: 1077
Study: 1997702

Group type: EXPERIMENTAL
Intervention: Estrogen treatment (150 micrograms ethinyl estradiol daily and 80 mg polyestradiol monthly)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Orchiectomy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 163
Study: 6150275

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Psychotherapy and placebo
Number of subjects: 30
Study: 31809265

Group type: EXPERIMENTAL
Intervention: Additional oral medications (0, 1, or 2+ medications)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) in girls
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Baseline depression
Number of subjects: 699
Study: 30022356

Group type: EXPERIMENTAL
Intervention: If I Were Jack intervention, teacher-delivered, focused on male and female responsibility in preventing unintended pregnancies
Number of subjects: 831

Group type: COMPARATOR
Intervention: Usual practice (Control)
Number of subjects: 831
Study: 27044941

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) with traditional osteotomies
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Piezosurgery with PRF
Number of subjects: 59

Group type: COMPARATOR
Intervention: Traditional burs (Control group)
Number of subjects: 59
Study: 23346871

Group type: EXPERIMENTAL
Intervention: Autogenous bone (AT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fresh-frozen allogeneic bone (AL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (AT and AL)
Number of subjects: 34
Study: 22858210

Group type: EXPERIMENTAL
Intervention: high-stress condition (social evaluation)
Number of subjects: 68

Group type: COMPARATOR
Intervention: low-stress condition (control)
Number of subjects: 68
Study: 20547760

Group type: EXPERIMENTAL
Intervention: Stage-matched intervention
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 226
Study: 18720573

Group type: EXPERIMENTAL
Intervention: Pain management education programme (7 sessions, 15 hours)
Number of subjects: 81
Study: 15656907

Group type: COMPARATOR
Intervention: Conservative care protocol (visits with a hand therapist, exercises, self-care booklet, work modification/activity restriction, B6 therapy, ultrasound, possible steroid injections)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Surgery (endoscopic vs. open, determined by the surgeon)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (Conservative care and Surgery)
Number of subjects: 200
Study: 12022708

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10363856

Group type: EXPERIMENTAL
Intervention: Stored leukocyte-reduced RBCs (n = 18)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Fresh nonleukocyte-reduced RBCs (n = 17)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (nontransfused preterm infants, n = 11)
Number of subjects: 46
Study: 7724172

Group type: EXPERIMENTAL
Intervention: 3.2‐mm incision
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 4.0‐mm incision
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 5.0‐mm incision
Number of subjects: 200
Study: 1782100

Group type: EXPERIMENTAL
Intervention: 100 IU sCT intramuscularly (i.m.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 110 IU sCT intranasally (i.n.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 200 IU sCT intranasally (i.n.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 400 IU sCT intranasally (i.n.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control day (no treatment)
Number of subjects: 12
Study: 6116084

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 30626939

Group type: EXPERIMENTAL
Intervention: DLK1 overexpression via adenovirus gene delivery
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Recombinant DLK1 extracellular domain (rDLK1-EC)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Blockade of Notch signaling using neutralizing antibody or pharmaceutical inhibitor
Number of subjects: 221
Study: 28353593

Group type: EXPERIMENTAL
Intervention: Warming infusion (fluid warmed to 35°C)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (room temperature infusion at 22-23°C)
Number of subjects: 64
Study: 26514332

Group type: EXPERIMENTAL
Intervention: Buccal spray (500 IU, delivering 1000 IU in two spray shots)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Soft gelatin capsule (1000 IU)
Number of subjects: 40
Study: 23313567

Group type: EXPERIMENTAL
Intervention: Inotropes
Number of subjects: 23

Group type: COMPARATOR
Intervention: No inotropes
Number of subjects: 23
Study: 20688437

Group type: EXPERIMENTAL
Intervention: Oxytocin reactivity measured in response to a laboratory task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline levels of oxytocin or cortisol reactivity
Number of subjects: 0
Study: 19301686

Group type: EXPERIMENTAL
Intervention: Baseline lipid measurements
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Gender analysis
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Education level analysis
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Geographic variation
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Adjustment for demographic factors
Number of subjects: 2368
Study: 17761229

Group type: EXPERIMENTAL
Intervention: Diet Quality Index-Revised (DQI-R) intervention
Number of subjects: 182

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 182
Study: 15514264

Group type: EXPERIMENTAL
Intervention: ALA Diet
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: LA Diet
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both high-PUFA diets
Number of subjects: 23
Study: 11344204

Group type: EXPERIMENTAL
Intervention: Morning hypoglycemia (2.9 +/‐ 0.1 mmol/L)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Euglycemic control (5.1 +/‐ 0.1 mmol/L)
Number of subjects: 24
Study: 10686414

Group type: EXPERIMENTAL
Intervention: Visual double-step perturbation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Same spatial goal with different likelihood of visual double-step
Number of subjects: 0
Study: 10437184

Group type: EXPERIMENTAL
Intervention: Massage with relaxation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no change in prescribed medication)
Number of subjects: 0
Study: 1440172

Group type: COMPARATOR
Intervention: One axillary drain
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Two drains (one in axilla, one beneath pectoral flaps)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Two drains
Number of subjects: 84
Study: 2580866

Group type: EXPERIMENTAL
Intervention: Acebutolol (600 mg tid)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol (80 mg tid)
Number of subjects: 14
Study: 31020598

Group type: EXPERIMENTAL
Intervention: Multidisciplinary antithrombotic stewardship
Number of subjects: 1886

Group type: EXPERIMENTAL
Intervention: Dosing of low-molecular-weight heparins (LMWHs)
Number of subjects: 1886
Study: 30051166

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study: 27712015

Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFIRI
Number of subjects: 117

Group type: COMPARATOR
Intervention: Bevacizumab plus FOLFIRI
Number of subjects: 117
Study: 24891327

Group type: EXPERIMENTAL
Intervention: LVR coil treatment
Number of subjects: 60
Study: 22955098

Group type: EXPERIMENTAL
Intervention: Information booklet with brief motivational interview
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Information booklet only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Informal discussion (control group)
Number of subjects: 60
Study: 20650046

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion 0.2 microg/kg/min (G1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion 0.2 microg/kg/min and low doses of ketamine infusion 1 microg/kg/min (G2)
Number of subjects: 30
Study: 18614998

Group type: EXPERIMENTAL
Intervention: HAART (highly active antiretroviral therapy)
Number of subjects: 508
Study: 15834326

Group type: EXPERIMENTAL
Intervention: Bupivacaine and methylprednisolone
Number of subjects: 86

Group type: COMPARATOR
Intervention: Bupivacaine only
Number of subjects: 86
Study: 11818344

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 37)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (n = 42)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 9920222

Group type: EXPERIMENTAL
Intervention: Mailed reminders during the immunization season of 1995
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 10000
Study: 8772222

Group type: EXPERIMENTAL
Intervention: Synthetic natural pentasaccharide (NP) administered subcutaneously at doses from 1.43 to 22.9 mg (1000 to 16,000 anti‐Xa IU)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Synthetic natural pentasaccharide (NP) administered at various dosages once or twice a day for 7 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Synthetic natural pentasaccharide (NP) at highest dose regimens (single injection of 26.6 mg and repeated injections of 11.4 mg)
Number of subjects: 20
Study: 2292115

Group type: EXPERIMENTAL
Intervention: TCM prescriptions of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Combination of Chinese medicine with chemotherapy
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Decoction given to mice bearing Ehrlich ascites tumor
Number of subjects: 158
Study: 30904947

Group type: COMPARATOR
Intervention: Control plots
Number of subjects: 0

Group type: COMPARATOR
Intervention: Herbivore-exclusion plots
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Species sharing bees as pollinators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher plot-level flowering time overlap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal niche differentiation
Number of subjects: 0
Study: 28185625

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-Stimulating Agents (ESAs)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: COMPARATOR
Intervention: Term healthy control
Number of subjects: 71
Study: 26401735

Group type: EXPERIMENTAL
Intervention: Intravenous sugammadex (2 mg kg⁻¹)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No reversal agents (Control Group II)
Number of subjects: 38
Study: 24098467

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day) in DM subgroup (n = 63)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day) in DM subgroup (n = 62)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 225
Study: 21320950

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy (melphalan with or without topotecan)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy
Number of subjects: 78
Study: 19158122

Group type: EXPERIMENTAL
Intervention: Low-dose oral theophylline (100 mg twice daily)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard therapy (including systemic steroids)
Number of subjects: 35
Study: 17338996

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (ROS)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 86
Study: 14741300

Group type: EXPERIMENTAL
Intervention: Cerebellar patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 11455279

Group type: COMPARATOR
Intervention: Conventional ultrafiltration (CUF)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Conventional plus modified ultrafiltration (CUF+MUF)
Number of subjects: 41
Study: 9586599

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18000
Study: 8061738

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody treatment for endotoxin-induced septic shock
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New techniques to supplement basic cardiopulmonary resuscitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribavirin treatment for respiratory syncytial virus infection in mechanically ventilated infants
Number of subjects: 0
Study: 2969169

Group type: EXPERIMENTAL
Intervention: 2 l O2/min
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 4 l O2/min
Number of subjects: 36

Group type: COMPARATOR
Intervention: No oxygen
Number of subjects: 36
Study: 31729999

Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral therapy (ART) starting within 7 days after initiation of opportunistic infection (OI) treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Deferred antiretroviral therapy (ART) starting after completing OI-therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 61

Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 61
Study: 28248676

Group type: EXPERIMENTAL
Intervention: 70% alcohol (single application in delivery room)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine (single application in delivery room)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: povidon-iodine (single application in delivery room)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: 70% alcohol (application every six hours until discharge)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine (application every six hours until discharge)
Number of subjects: 516

Group type: COMPARATOR
Intervention: dry care
Number of subjects: 516
Study: 25319717

Group type: EXPERIMENTAL
Intervention: Self-affirmation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perspective exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard self-affirmation manipulation
Number of subjects: 0
Study: 23809455

Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-bundle (SB) ACL reconstruction
Number of subjects: 80
Study: 22204723

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg daily) plus elastic stockings with graduated compression
Number of subjects: 8307

Group type: COMPARATOR
Intervention: Placebo plus elastic stockings with graduated compression
Number of subjects: 8307
Study: 18196200

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment during TMS
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study: 16544582

Group type: EXPERIMENTAL
Intervention: Rofecoxib (R) 25mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 19
Study: 12635916

Group type: EXPERIMENTAL
Intervention: Dominant confederate (postural expansion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Submissive confederate (postural constriction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complementarity (dominance in response to submission and submission in response to dominance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complementarity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mimicry
Number of subjects: 0
Study: 10711861

Group type: EXPERIMENTAL
Intervention: Oral L-arginine (9 g daily for 1 month)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9198053

Group type: EXPERIMENTAL
Intervention: Na+ lactate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Na+ HCO3‐
Number of subjects: 40
Study: 1534048

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 278

Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 278
Study: 3899317

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 132

Group type: COMPARATOR
Intervention: Untreated patients (Control)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Premedicated patients (within 75-200 minutes of surgery)
Number of subjects: 132
Study: 29793929

Group type: EXPERIMENTAL
Intervention: Fixed incentive (£10 cash for attending screening)
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: Lottery incentive (1 in 100 chance of winning £1000)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Control (usual invitation letter)
Number of subjects: 1051
Study: 28802103

Group type: EXPERIMENTAL
Intervention: Sensorimotor alignment (participants' to-be-imagined orientation aligned with physical orientation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensorimotor misalignment (participants' to-be-imagined orientation misaligned with physical orientation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Similar geometry between learning and test environments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different geometry between learning and test environments
Number of subjects: 0
Study: 25601322

Group type: EXPERIMENTAL
Intervention: Spermatozoa treated with myoinositol
Number of subjects: 500

Group type: COMPARATOR
Intervention: Spermatozoa treated with placebo
Number of subjects: 500
Study: 24021033

Group type: EXPERIMENTAL
Intervention: Goal-setting intervention during asthma review consultation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care guideline-based review of asthma
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Goal-setting intervention
Number of subjects: 80
Study: 21226939

Group type: EXPERIMENTAL
Intervention: Titrated therapeutic hypothermia (32-35 °C) with intravenous 0.9% saline (20-30 ml/kg) and maintained for at least 48 hours or longer as needed to keep intracranial pressure <20 mmHg.
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 1800
Study: 18653816

Group type: EXPERIMENTAL
Intervention: Medication Discharge Plan (MDP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 83
Study: 16863712

Group type: EXPERIMENTAL
Intervention: EC-high-buffered pancrelipase
Number of subjects: 18

Group type: COMPARATOR
Intervention: EC-nonbuffered enzymes
Number of subjects: 18
Study: 15648730

Group type: EXPERIMENTAL
Intervention: Sequence condition (repeating sequence of three problems)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Random condition (nonrecurring problems)
Number of subjects: 36
Study: 11410720

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 microg/kg twice a day) and naltrexone (25 mg twice a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9248764

Group type: EXPERIMENTAL
Intervention: Calcitriol 1 microgram per day for 5 consecutive days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) 60 mg.kg-1 on day 1 plus calcitriol 1 microgram per day orally for 5 consecutive days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) 60 mg.kg-1 on day 1
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 8363113

Group type: COMPARATOR
Intervention: N‐acetylcysteine (140 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Activated charcoal (60 g) + N‐acetylcysteine (235 mg/kg)
Number of subjects: 10
Study: 3306781

Group type: EXPERIMENTAL
Intervention: Iopamidol (nonionic agent)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Iothalamate meglumine (ionic agent)
Number of subjects: 54
Study: 31738378

Group type: EXPERIMENTAL
Intervention: Self-testing (ST) group received 4 HIV self-tests and access to online resources and counseling.
Number of subjects: 2665

Group type: EXPERIMENTAL
Intervention: Self-testing (ST) group
Number of subjects: 2665

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2665
Study: 30107239

Group type: EXPERIMENTAL
Intervention: RHO guided oxygen weaning
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard home oxygen therapy management
Number of subjects: 196
Study: 26429200

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day with ubiquinol supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 25265769

Group type: EXPERIMENTAL
Intervention: Intrathecal hyperbaric bupivacaine 10 mg plus fentanyl 10 g
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine 11 mg plus fentanyl 10 g
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intrathecal levobupivacaine 11 mg plus fentanyl 10 g
Number of subjects: 90
Study: 22430286

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery bypass surgery (CABG)
Number of subjects: 0
Study: 20404738

Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 0
Study: 18779612

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg/d orally)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Vinorelbine (30 mg/m2 infusion on days 1 and 8 of a 21-day cycle)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: EGFR FISH-positive patients
Number of subjects: 196
Study: 15929952

Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg q.d. for 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Refractory asthma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild-to-moderate asthma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0